Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2212
https://www.valueinhealthjournal.com/article/S1098-3015(16)33578-1/fulltext
Title : Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33578-1&doi=10.1016/j.jval.2016.09.2212
First page : A733
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2099
Categories :
Tags :
Regions :
ViH Article Tags :